PureTech Health News
Press releases
Press releases 2018-05-18
Results of Annual General Meeting

The Annual General Meeting of PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), was held at 3.00 pm BST on Friday 18 May 2018. All of the resolutions proposed at the Annual General Meeting were duly passed by the shareholders on a poll. 

CONTINUE

Press releases 2018-05-09
Cognitive Interference Processing
PureTech’s Akili Raises $55 Million to Advance Digital Medicine Platform and Product Pipeline Aimed at Treating Cognitive Dysfunction

Proceeds will advance commercial and clinical stage pipeline in ADHD, multiple sclerosis, and depression

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliate, Akili Interactive (“Akili”), has successfully completed a $55 million financing round. This financing was led by Temasek and included both new and existing strategic and institutional investors Baillie Gifford, Amgen Ventures, M Ventures (the CVC fund of Merck KGaA, Darmstadt, Germany), Jazz Venture Partners, Canepa Advanced Healthcare Funds, and Brooklands Capital Strategies.

Continue
Press releases 2018-05-02
Vocal Biomarkers
PureTech Health Affiliate Sonde Adds Thai Lee to Board of Directors

Appointment brings extensive business growth experience to affiliate’s Board of Directors

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, is pleased to note that Sonde Health, an affiliate of PureTech Health, today announced the appointment of Thai Lee to its Board of Directors. Ms Lee is recognised as a prominent business leader in the information technology industry and brings more than two decades of experience to Sonde’s Board of Directors.

Continue
Press releases 2018-04-24
PureTech Health Appoints Joep Muijrers as Chief Financial Officer

Life sciences veteran brings strong track record of portfolio management, M&A, partnerships, IPOs, equity financings, and capital finance

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, is pleased to announce today the appointment of Joep Muijrers, as the Company’s Chief Financial Officer after 11 successful years as a Partner and Portfolio Manager at LSP (Life Sciences Partners), a trans-Atlantic investor group with exclusive focus on life sciences, where he helped several companies become leaders in the biopharma industry and generated tremendous value for his firm’s stakeholders.

Continue
Press releases 2018-04-16
PureTech Health Announces Annual Results for Year Ended 31 December 2017
Press releases 2018-04-10
PureTech Health Affiliates Expand Digital Medicine IP Portfolios with Key Patent Issuances

US and international patent grants for Akili and Sonde technology platforms highlight PureTech’s foundational leadership position in the growing field of digital medicine

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliates, Akili Interactive Labs, Inc. and Sonde Health, Inc., have been granted key patents broadly covering their respective proprietary technology platforms.

Continue
Press releases 2018-04-09
Microbiome-Derived Immune Modulators (Pediatric)
PureTech’s Commense Appoints President and Chief Executive Officer

Biotechnology veteran brings strong track record of strategic business development

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today the appointment of Edward J. “Tad” Stewart as President and Chief Executive Officer of its affiliate, Commense.

Continue
Press releases 2018-04-04
Inflammation-Targeting Technology
PureTech’s Alivio Technology Published in Nature Communications

Study demonstrates application of inflammation-responsive technology platform for the treatment of inflammatory diseases

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today that a preclinical study of the Alivio inflammation-responsive technology has been published in one of the leading scientific journals, Nature Communications.

Continue
Press releases 2018-02-01
GI Modulating Tunable Hydrogel
PureTech’s Gelesis Raises $30 Million to Prepare for Potential Launch of Lead Product

Proceeds to be used for manufacturing and commercialisation preparations and advancement of the Company’s clinical development pipeline

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today that Gelesis, an affiliate of PureTech Health, has successfully completed a $30 million financing round.

Continue
Press releases 2018-01-31
Selective mTORC1 Inhibitors
PureTech Affiliate resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Continue

@PureTechH